NOTES - For the purposes of applying the sanctions contained in the present regulations, all products, whatever their name, which contain the substances listed, even as a minor constituent, must be regarded as prohibited.

 

VERY IMPORTANT - NEW REQUIREMENT EFFECTIVE FROM 1 JANUARY 2004
All Riders using formoterol, salbutamol, salmeterol and terbutaline inhalers or insulin for the treatment of a medical condition are required to register an appropriate medical certificate with the General Secretary of the British Cycling Federation. They are also advised to obtain a number of copies so that one is available and can be given to the Anti-Doping Inspector to attach one to the sampling forms. The best option is to carry a copy of the certificate with you to events. Failure to register shall not constitute grounds for any appeal against a charge in respect of a breach of the UCI or Cycling Time Trials Anti-Doping Regulations.

 
WARNING - Many of these drugs appear either alone or as mixtures in medication under a commercial title. It is thus essential that, should there be any doubt, expert advice should be sought by the competitor from a doctor, pharmacist or the General Secretary of British Cycling Federation BEFORE taking any medication. The lack of the knowledge that a particular substance is banned shall not constitute grounds for any appeal against a charge in respect of a breach of the UCI or Cycling Time Trials Anti-Doping Regulations.

IF IN DOUBT - CHECK IT OUT WITH THE BCF

NOTE  -  The Cycling Time Trials  Anti-Doping Regulations are subject to periodic review and change due to factors which are outside the control of the Company (e.g. changes introduced or advised by the Union Cycliste Internationale, the International Olympic Committee, UK Sport or the World Anti-Doping Agency).  In view of this anyone requiring up to date information on any changes which may have taken place since the publication of the current Regulations can obtain this from:-

Jim Hendry, General Secretary, British Cycling Federation

St. Kilda” 62 St.Saviour’s Road, Kettering, Northants. NN15 5EJ

Tel: 01536 483695       Fax: 01536 483695

E-mail gensec@britishcycling.org.uk

List Of Banned Substances & Methods

As amended 1 January 2004

Compiled by the U.C.I. Anti-Doping Commission, in liaison with the U.C.I. Medical Commission pursuant to Articles 1 - 13 of the U.C.I. Anti-Doping Examination Regulations and approved by the U.C.I.  Applicable to all events under the Rules & Regulations of Cycling Time Trials from 1 January 2004.

This list is based on that of the International Olympic Committee but is not exactly the same.  Items in respect of controls outside of competition are as agreed between UK Sport and the British Cycling Federation.

I   PROHIBITED CLASSES OF SUBSTANCES

            A.            Stimulants

            B.            Narcotics

            C.            Anabolic Agents

                        1.            Androgenic anabolising steroids

2.                Non-steroidal anabolic agents

            D.            Diuretics.

            E.            Peptide Hormones, mimetics and analogues

II   PROHIBITED METHODS

A.                   Blood Doping

B.                   Administration of products likely to artificially increase the supply of oxygen or of plasma volume expanders.

C.                  Pharmacological, chemical or physical manipulation

III   CLASSES OF PROHIBITED SUBSTANCES SUBJECT TO CERTAIN CONDITIONS

         A.   Marijuana and other cannabinoids

         B.   Glucocorticosteroids

IV    SUBSTANCES PROHIBITED FOR CONTROLS OUTSIDE OF COMPETITION

         A.   Anabolic Agents

         B.   Peptide hormones, mimetics and analogues

C             Masking agents such as: bromantan, probenecid, epitestosterone, diuretics

D                        The following amphetamines-related products and stimulants :

amineptine mesocarb

amphetamine methoxyphenamine

amphetaminil methylamphetamine

bambuterol methylphenidate

benzphetamine morazone

carphedon pemoline

cocaine phendimetrazine

dimethylamphetamine phenmetrazine

ethylamphetamine pipradol

fenethylline pyrovalerone

fenproporex reproterol

formoterol selegiline

furfenerox and related substances

E.           Compounds chemically or pharmacologically related to those under A) to C) above.

         F    Prohibited methods

Notes:

1             This list stays in effect until a new list is published.

2             It is recalled that under the Anti-Doping Examination Regulations, all products, regardless of denomination, that contain even a minor amount of the above mentioned substances are prohibited.

3             Warning: the listings of examples in this document are not exhaustive!  Numerous substances that are not itemised in this list are considered prohibited under the designation of “related substances”.  Riders and other licence holders must make sure that every drug, supplement, preparation, particularly if sold over-the-counter, as well as every other substance they use does not contain any prohibited substance.

4             Warning: this list relates to a sports regulation.  The use of, and traffic in, a number of substances on this list is prohibited or regulated in the national laws of many countries.  Provisions for criminal penalties may be laid down.  A substance or method that is not prohibited under the present list may be prohibited under national law, as for example with regard to cannabinoids.

EXAMPLES & EXPLANATIONS

I   CLASSES OF PROHIBITED SUBSTANCES

(A)     STIMULANTS:    

and related substances

as well as:

cathine (norpseudoephedrine)

for cathine (norpseudoephedrine) a sample shall be deemed positive if the concentration in the urine exceeds 5 micrograms/ml.

            ephedrine ***  

methylephedrine

for ephedrine and methylephedrine a sample shall be deemed positive if the concentration in the urine exceeds 10 micrograms/ml.

phenylpropanolamine

for phenylpropanolamine, a sample shall be deemed positive if the concentration in the urine exceeds 25 micrograms/ml.

formoterol

salbutamol

salmeterol

terbutaline

Formoterol, salbutamol, salmeterol and terbutaline are permitted in the form of aerosols for the purpose of preventing and/or treating asthma and stress related asthma

Asthma and/ or stress related asthma must be confirmed by a lung specialist or a team doctor.  The rider must produce a medical certificate and a prescription issued by a lung specialist or a team doctor during the drug tests (for riders of Trade Teams I and II only the registration on the health record booklet will be taken into consideration).   If he does not comply with this, and the laboratory finds traces of one of those substances, he will be considered positive.  For salbutamol, a concentration of less than 100 nanograms per millilitre will not be taken into consideration.

         (B)    NARCOTIC ANALGESICS   e.g. :      

alphaprodine methadone

anileridine morphine *

buprenorphine nalbuphine

dextromoramide pentazocine

diamorphine (heroin) pethidine

dipipanone phenazocine

ethoheptazine trimeperidine

levorphanol        and related substances

* For morphine a sample shall be deemed to be positive if the concentration in the urine exceeds 1 microgram/ml.

         NOTES: -              Codeine, dihydrocodeine, dextropropoxyphene, dextromethorphan ,diphenoxylate

ethylmorphine, propoxyphene, tramadol and pholcodine are permitted.

         (C)    ANABOLIC AGENTS

            1.   Androgenic Anabolic Steroids * e.g.

androstenediol methandienone

androstenedione methyltestosterone

bolasterone nandrolone***

boldenone 19-norandrostenediol

clostebol 19-norandrostenedione

dehydrochlormethyltestosterone norethandrolone

dehydroepiandrosterone oxandrolone

dihydrotestosterone** oxymesterone

fluoxymesterone oxymetholone

gestrinone stanozolol

mesterolene testosterone****

methenolone       and related substances

* Cycling Time Trials can have any sample or part of a sample analysed by a Gas-chromatography/Combustion/Isotope Ratio Mass Spectrometry (GC/C/IRMS) in any laboratory which has this apparatus.  Cycling Time Trials will inform the rider about this.  If this analysis confirms exogenous application, the rider will be considered positive.  In other cases, Cycling Time Trials can ask for further tests.  If the rider refuses to undergo these tests, he will be considered positive.

** For dihydrotestosterone a sample will be considered positive if the concentrations of dihydrotestosterone and its metabolites and/or their ratio of non-5alpha steroids exceed the normal level of a human being in such a way that they cannot be attributed to endogenous production.

*** For nandrolone and its derivatives, a sample will be considered positive if the norandrosterone concentration found in the urine after hydrolysis exceeds 5 ng/ml.  If the concentration is between 2 and 5 ng/ml or is equal to 5 ng/ml, Cycling Time Trials can request further analyses.  If the rider refuses to undergo them, he will be considered positive.

**** For analyses other than those performed with a GC/C/IRMS apparatus (see point * above) a sample will be considered positive for testosterone if the level of testosterone/epitestosterone (T/E) is higher than 6.

• Nevertheless, the rider can request an endocrinological examination to determine if the level is due to a physiological or pathological state. 

·        The request for the endocrinological examination must be made to Cycling Time Trials at the latest 5 working days after receipt of the letter notifying the rider of the positive result, i.e. within the deadline for the request of a counter-analysis.  Cycling Time Trials will decide which laboratory and date will be chosen for the analysis.  The cost of the analysis must be paid in advance by the rider.  The date of the analysis cannot be postponed.  If the results of the endocrinological examination show that that the level of T/E is due to a physiological or pathological state, Cycling Time Trials will refund to the rider the cost of the examination and issue him with a certificate. In all other cases the cost of the examination is to be paid by the rider.

·        If the rider requests a counter-analysis, he must do so within the deadline stipulated in article 51 of the Anti-Doping Regulations, even if he requests an endocrinological examination.  If the counter-analysis does not confirm the a positive result, the rider will not be considered positive and the endocrinological examination will not be conducted.

·        Instead of an endocrinological examination the rider can request, within the same deadline, that Cycling Time Trials carries out a retrospective analysis of previous results, which should be addressed to the Board within 3 working days of the request.  If Cycling Time Trials judges that the request is not valid, it may oblige the rider to have an endocrinological examination.  If the circumstances are justifiable, Cycling Time Trials may immediately propose a retrospective analysis.

·        Cycling Time Trials may also demand a long term examination consisting of random tests conducted during a period, which it will determine.

2   Non-Steroidal Anabolic Agents e.g.

bambuterol clenbuterol fenoterol

formoterol* reproterol salbutamol*

salmeterol*         terbutaline*              zeranol

     and related substances

*   Except with a therapeutic justification for use by inhaling under point I A 1, for salbutamol a sample shall be considered as positive in the class of anabolic agents if the concentration in the urine exceeds 1000 nanograms per millilitre.

            (D)            DIURETICS

            acetazolamide                                       hydrochlorothiazide

            bumetanide                                          mannitol *

            chlorthalidone                                       mersalyl

            ethacrynic acid                                     spironolactone

            furosemide                                            triamterine

                                                                             and related substances.

         *         prohibited by intravenous injection.

(E)       PEPTIDE HORMONES MIMETICS AND ANALOGUES

Chorionic gonadotrophin (hCG - Human Chorionic Gonadotrophin – prohibited in males only) :

It is well known that the administration of Human Chorionic Gonadotrophin (hCG) or other related compounds leads to an increase in the production of natural androgenic steroids and is considered equivalent to the exogenous administration of testosterone.

A sample would be considered positive if the concentration is above  20 ImU/ml. During the analysis two different immunoassay methods must be used.

Pituitary and Synthetic Gonadotrophins – (LH - Prohibited in males only)

Corticotrophin (ACTH., tetracosactide) : Corticotrophin has been misused to increase the levels of endogenous corticosteroids in the blood, particularly to obtain the mood elevating effect of corticosteroids.  The administration of Corticotrophin is considered to be equivalent to the oral, intramuscular or intravenous application of corticosteroids (See section III.C).

Growth Hormone (hGH, Somatotrophin): The use of Growth Hormone in sport is regarded as unethical and dangerous because of various adverse side-effects, for example, allergic reactions, diabetogenic effects and acromegaly when administered in large doses.

Insulin-like Growth Factor (IGF-1):

Erythropoietin (EPO): A glycoproteinic hormone produced in the human kidney which regulates, apparently by retroaction, the rate of synthesis of erythrocytes.

Insulin:  Permitted only to treat insulin-dependent diabetes.  Written notification of insulin-dependent diabetes by an endocrinologist is required (for riders of Trade Teams 1 and II only the registration on the health record booklet will be taken into consideration).  All Riders with insulin dependent diabetes are required to register a certificate from their GP with the General Secretary of British Cycling.

Also prohibited for males are clomiphene, cyclofenil and tamoxifen and aromatose inhibitors.

Without prejudice to the concentration stipulated for hCG., the presence of an abnormal concentration of an endogenous hormone in Class (E) or its diagnostic marker(s) in the urine of a competitor constitutes an offence unless it has been proven to be due to a physiological or pathological condition.

II   PROHIBITED METHODS

         (A)   Blood Doping and Artificial Oxygen Carriers (for example PFC)

Blood doping is the administration of blood, red blood corpuscles or related substances to an athlete except for proven medical need.  This procedure may be preceded by the taking of blood from the athlete, who then continues with his training in a state of lacking sufficient blood.

Blood transfusion is the intravenous administration of red blood corpuscles or blood compounds containing red corpuscles.  These products may be obtained from blood extracted either from the same individual (auto-transfusion) or from different individuals (hetero-transfusion).  The most common indication for the transfusion of red blood corpuscles in current traditional medicine is a large blood loss or severe anaemia.  Except where there is a clear medical indication, blood transfusion constitutes doping.

(B)         Administration of products likely to artificially increase the supply of oxygen or of plasma volume expanders

Apart from the fact that these are prohibited methods, it is worth stressing the risks associated with the transfusion of blood, blood products or products likely to artificially increase the supply of oxygen (e.g. RSR-13, PFC or synthetic haemoglobin).  These risks include the development of allergic reactions (skin rashes, fevers etc.) as well as acute haemolytic reactions with kidney damage if an incorrect blood type is used, as well as delayed reactions to transfusion such as fever or jaundice, the transmission of infectious diseases (viral hepatitis and AIDS), the overloading of the circulatory system and metabolic shock.

The terms plasma volume extenders are understood to mean, for example, gelatine solutions, polysaccharide solutions (for example hydroxyethylamidon {HEA}, dextran, albumin-based solutions).

         (C)   Pharmacological, Chemical or Physical Manipulation

Cycling Time Trials and the UCI Anti-Doping Commissions prohibit the use of substances and methods, including masking agents, which alter, try to alter, or carry a reasonable risk of altering the integrity and validity of the samples used in doping controls.

Prohibited Methods :  for example, but not an exhaustive list, are catheterisation; the substitution and/or alteration of urine; the alteration of renal excretion, the alteration of measurements taken on testosterone and epitestosterone.

Prohibited substances, for example, but not an exhaustive list, are probenecid and related compounds; epitestosterone, bromantan.

If the concentration of epitestosterone is above 200 nanograms/ml, laboratories are requested to notify the authorities concerned.  The Anti-Doping Commissions recommend in this event that additional checks be carried out.

III    CATEGORIES OF SUBSTANCES SUBJECT TO CERTAIN RESTRICTIONS

         (A)   Marijuana and other cannabinoids.

            Marijuana is prohibited in the “downhill” discipline of mountain biking.  A sample shall be deemed positive if the concentration in the urine exceeds 40ng/ml of THC-COOH (main metabolite of cannabis)..

         (B)     Glucocorticosteroids

The use of glucocorticosteroids is permitted on the following conditions:

1                 If the application is local: auricular, ophthalmologic or dermatological or local injection (e.g. intra-auticular); in case of justification for asthma or allergic rhinitis, it can be used by inhalation:

a it must be justified on medical grounds

b            justification on medical grounds and the method of application must be proved by the rider in the form of a medical certificate.  For riders of Trade Teams 1 and 11, only the registration on the health record booklet will be taken into consideration.

2                 If the application is systemic:

a            it must be justified on medical grounds

b a document must be presented to the UCI Anti-Doping Commission.

c the consent of the Anti-Doping Commission must be obtained: except if the medical urgency is incompatible with the consent, this written consent must be obtained before the application.

d the application must be registered in the health record booklet

e the above procedure must be followed in the case of treatment renewal.

Except for the conditions cited above, the use of glucocorticosteroids is prohibited.